Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation

被引:46
|
作者
Moins-Teisserenc, Helene [1 ,2 ]
Busson, Marc [2 ]
Scieux, Catherine [3 ]
Bajzik, Veronique [2 ]
Cayuela, Jean-Michel [4 ]
Clave, Emmanuel [2 ]
de Latour, Regis Peffault [5 ,6 ,7 ]
Agbalika, Felix [3 ]
Ribaud, Patricia [5 ]
Robin, Marie [5 ]
Rocha, Vanderson [5 ]
Gluckman, Eliane [5 ]
Charron, Dominique [2 ]
Socie, Gerard [5 ,6 ,7 ]
Toubert, Antoine [2 ]
机构
[1] Hop St Louis, Inst Univ Hematol, INSERM, U662, F-75010 Paris, France
[2] Ctr Invest Biomed Hematol Oncol Greffes, Lab Immunol & Histocompatibil, Paris, France
[3] Hop St Louis, Microbiol Lab, Paris, France
[4] Hop St Louis, Hematol Lab, Paris, France
[5] Hop St Louis, Serv Hematol Greffe, Paris, France
[6] Hop St Louis, AP HP, INSERM U728, Paris, France
[7] Univ Paris 07, Paris, France
来源
JOURNAL OF INFECTIOUS DISEASES | 2008年 / 198卷 / 06期
关键词
D O I
10.1086/591185
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tcell -mediated immunity is essential for the control of cytomegalovirus(CMV) infections in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Our aims were to identify patterns of CMV-specific immune responses associated with multiple or prolonged reactivations. We analyzed findings in 116 recipients during the course of infection or reactivation and latency. CD8 (+) T cell responses were determined weekly, using HLA class I tetramers together with extended phenotypic analyses. Our results confirmed that recipients of allo-HSCT from unrelated donors were more susceptible to multiple reactivations and that the donor's CMV serological status influenced the occurrence of prolonged reactivations. We found that a lack of CMV-specific T cells after the first episode of reactivation was associated with multiple subsequent reactivations. In patients with uncontrolled reactivations, CMV-specific T cells of the late differentiation phenotype CD45RA (+) CD27(-)CD28-did not develop. Longitudinal evaluation of CD27 and CD45RA expression within the tetramer-positive subset could help identify patients in whom a protective immune response is developing. Evaluation of CMV-specific immune responses during the first episode of reactivation, together with extended phenotypes, could thus improve immune monitoring, especially in recipients at risk of uncontrolled viral reactivation.
引用
收藏
页码:818 / 826
页数:9
相关论文
共 50 条
  • [1] Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic haematopoietic stem cell transplantation
    Moins-Teisserenc, H.
    Busson, M.
    Scieux, C.
    Bajzik, V.
    Cayuela, J. M.
    Clave, E.
    de latour, R. Peffault
    Agbalika, F.
    Ribaud, P.
    Robin, M.
    Rocha, V.
    Gluckman, E.
    Charron, D.
    Socie, G.
    Toubert, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S48 - S49
  • [2] Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Selective Control of JC Virus Reactivation
    Tan, Chen Sabrina
    Broge, Thomas A., Jr.
    Ngo, Long
    Gheuens, Sarah
    Viscidi, Raphael
    Bord, Evelyn
    Rosenblatt, Jacalyn
    Wong, Michael
    Avigan, David
    Koralnik, Igor J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (07) : 992 - 999
  • [3] Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
    Hakki, M
    Riddell, SR
    Storek, J
    Carter, RA
    Stevens-Ayers, T
    Sudour, P
    White, K
    Corey, L
    Boeckh, M
    BLOOD, 2003, 102 (08) : 3060 - 3067
  • [4] Immune reconstitution of human cytomegalovirus-specific T lymphocytes after allogeneic hematopoietic stem cell transplantation and their predictive role in reactivation
    Zhao, Yuanqi
    Zhen, Sisi
    Wang, Jiali
    Wang, Jieru
    Ma, Runzhi
    Liu, Li
    Pang, Aiming
    Zhang, Rongli
    Chen, Xin
    Zhai, Weihua
    Yang, Donglin
    He, Yi
    Han, Mingzhe
    Jiang, Erlie
    Feng, Sizhou
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [5] Impact of natural killer cell reconstitution on outcomes in patients with early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
    Kanamori, Heiwa
    Ando, Taiki
    Ishiyama, Yasufumi
    Tachibana, Takayoshi
    Tanaka, Masatsugu
    Nakajima, Hideaki
    BONE MARROW TRANSPLANTATION, 2019, 54 : 429 - 430
  • [6] The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
    Mardani, Masoud
    Abolghasemi, Sara
    Shabani, Shiva
    Tavakoli, Farzaneh
    Saeedi, Anahita
    Parkhideh, Sayeh
    Hajifathali, Abbas
    IRANIAN JOURNAL OF MICROBIOLOGY, 2020, 12 (06) : 636 - 643
  • [7] Distinct Immune Reconstitution Profiles Captured by Immune Functional Assays at 6 Months Post Allogeneic Hematopoietic Stem Cell Transplantation
    Mouton, William
    Conrad, Anne
    Alcazer, Vincent
    Boccard, Mathilde
    Bodinier, Maxime
    Oriol, Guy
    Subtil, Fabien
    Labussiere-Wallet, Helene
    Ducastelle-Lepretre, Sophie
    Barraco, Fiorenza
    Balsat, Marie
    Fossard, Gaelle
    Brengel-Pesce, Karen
    Ader, Florence
    Trouillet-Assant, Sophie
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (02): : 94.e1 - 94.e13
  • [8] The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantation
    Pei, Xu-Ying
    Huang, Xiao-Jun
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (05) : 513 - 524
  • [9] Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide
    Hebert, Courtney
    Watts, Nicole
    Isaac, Shiney
    Kukkamalla, Rivvi
    Jamy, Omer
    Saad, Ayman
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S276 - S277
  • [10] Antibacterial antibiotic exposures and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
    Zhang, Shijia
    Shanley, Ryan
    Rashidi, Armin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)